EGFR and neoplasm: While studies have reported DYRK1A to be implicated in oncogenic pathways such as EGFR stabilization36, resisting apoptosis17, promoting angiogenesis37, and overcoming stress response38, others found that DYRK1A could act as a tumor suppressor by inducing quiescence and senescence28.